2012Unpublished venueRequires access

Clinical study of Moxifloxacin injection in treatment of bacterial infections of respiratory tract

LI Yong-f

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy and safety of moxifloxacin injection in the treatment of respiratory tract bacterial infections.Methods A total of 60 patients were randomly divided into treatment group and control group(30 in each).The treatment group was treated with moxifloxacin injection,the control group was treated with levofloxacin injection both groups were treated for 7~14d.Results The total clinical effective rate was 93.3%in treatment group and 76.7% in control group(P0.05).The bacterial eradication rate in treatment group and in control group were 92.0% and 80.8% respectively(P0.05).There was significant difference between two group in the clinical efficacy.The incidence rate of adverse reactions was 13.3% in the treatment group and 16.7% in the control group(P0.05).Conclusion Moxifloxacin injection is an effective and safe antibiotics for the treatment of respiratory tract bacterial infections.

About this research paper

What this paper is about

Objective To evaluate the efficacy and safety of moxifloxacin injection in the treatment of respiratory tract bacterial infections.Methods A total of 60 patients were randomly divided into treatment group and control group(30 in each).The treatment group was treated with moxifloxacin injection,the control group was treated with levofloxacin injection both groups were treated for 7~14d.Results The total clinical effective rate was 93.3%in treatment group and 76.7% in control group(P0.05).The bacterial eradication rate in treatment group and in control group were 92.0% and 80.8% respectively(P0.05).There was significant difference between two group in the clinical efficacy.The incidence rate of adverse reactions was 13.3% in the treatment group and 16.7% in the control group(P0.05).Conclusion Moxifloxacin injection is an effective and safe antibiotics for the treatment of respiratory tract bacterial infections.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy and safety of moxifloxacin injection in the treatment of respiratory tract bacterial infections.Methods A total of 60 patients were randomly divided into treatment group and control group(30 in each).The treatment group was treated with moxifloxacin injection,the control group was treated with levofloxacin injection both groups were treated for 7~14d.Results The total clinical effective rate was 93.3%in treatment group and 76.7% in control group(P0.05).The bacterial eradication rate in treatment group and in control group were 92.0% and 80.8% respectively(P0.05).There was significant difference between two group in the clinical efficacy.The incidence rate of adverse reactions was 13.3% in the treatment group and 16.7% in the control group(P0.05).Conclusion Moxifloxacin injection is an effective and safe antibiotics for the treatment of respiratory tract bacterial infections.

Key concepts: Medicine, Levofloxacin, Moxifloxacin, Respiratory tract infections, Antibiotics, Respiratory tract, Adverse effect, Incidence (geometry)

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical study of Moxifloxacin injection in treatment of bacterial infections of respiratory tract — Research Paper | ScholarLens